Search Results for: us stem cell

Athersys & Mesoblast stem cells for COVID-19?

2019-nCoV-COVID-19-Pasteur

Could two stem cell biotechs Athersys and Mesoblast help in the battle against the novel coronavirus disease COVID-19? Stem cells, ARDS, and COVID-19 I’ve already written two pieces about the idea of using stem cells to battle COVID-19 (here and here), the sometimes fatal disease that arises from infection with the novel coronavirus. Older patients […]

Athersys & Mesoblast stem cells for COVID-19? Read More »

‘We Cannot Stick to the Rules’: claims of stem cells saving COVID-19 patients

stem-cells-for-COVID-19

I’ve been watching as the number of registered stem cell-related clinical trials for the novel coronavirus (SARS-CoV-2) disease COVID-19 continues to spiral upward, mostly in China. During the last two weeks, I’ve been trying to carve out a bit of time to look at these actual trials in more depth, but I admittedly haven’t gotten

‘We Cannot Stick to the Rules’: claims of stem cells saving COVID-19 patients Read More »

Weekly recommended science reads: stem cells, CRISPR, cancer & more

CRISPR-for-muscular-dystrophy.-Zhang-et-al.-Science-2020.-Screenshot-of-Fig.-2-featured-image

There’s never enough time to get all of one’s science reading done, but we can try! It helps to have a list of “to-read” articles, whether actual research articles or media pieces. In the old days, I remember my mentors saying they literally had “piles” of journal articles on their coffee tables, bathrooms, bedrooms, etc.

Weekly recommended science reads: stem cells, CRISPR, cancer & more Read More »

Reprimand, $13K fine for bone marrow stem cell clinic doc

Dr_Matthew_Thorson

A Minnesota doctor running a stem cell clinic offering bone marrow injections for a variety of health conditions was subject to action by state medical regulators. The Star Tribune’s reporter Jeremy Olson has a new article on the action, which included a $13K+ fine. Olson’s piece has some of the key details: “Dr. Matthew Thorson

Reprimand, $13K fine for bone marrow stem cell clinic doc Read More »

Stem cell good news, cool pubs, & some hype on living robots

Xenobots

Over time I seem to collect more upbeat stories about stem cells and regenerative medicine as well as cool publications  so today’s “good news” post is a collection of these kinds of things plus one example of huge science hype. Here’s a list of past such upbeat posts. The preclinical good news in rats from

Stem cell good news, cool pubs, & some hype on living robots Read More »

In landmark step, judge does not defer to FDA in stem cell clinic chain case, orders full trial

Judge-Jesus-Bernal

In what could be a serious legal warning sign for the stem cell field, California federal district court Judge Jesus Bernal denied the government’s motion for summary judgement against Cell Surgical Network, et al. related to their marketing of an unproven fat stem cell product via their chain of clinics. The FDA is seeking a

In landmark step, judge does not defer to FDA in stem cell clinic chain case, orders full trial Read More »

IPS cell field update: easy culture, Parkinson’s, scarring, immune cells, & mutations

Fibrosis-model-IPS-cells-Fig-1b-Vijayaraj-et-al-Cell-Reports-2019

Where do things stand today in 2020 with IPS cell research? It’s been 14 years since they were first reported, but they continue to make news. Back in 2006 I was wrapping up my postdoc with Bob Eisenman at The Hutch in Seattle, largely studying Myc, when Shinya Yamanaka published his first induced pluripotent stem

IPS cell field update: easy culture, Parkinson’s, scarring, immune cells, & mutations Read More »

As Goop Lab TV show approaches, my look at their ‘stem cell’ products

Gwyneth-Paltrow-of-Goop-Labs

Gwyneth Paltrow has a new Netflix show coming up in a couple of weeks called “The Goop Lab” and her Goop company promotes a lot of wacky things so one Sunday over lunch I thought I’d take a look at what they sell related to stem cells. Going into this, I didn’t know for sure

As Goop Lab TV show approaches, my look at their ‘stem cell’ products Read More »